13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$1.01T
+5.0% on the quarter before
Positions
5,337
462 new · 430 sold out
Top 10
23.6%
of the value
Est. gain
+$58.23B
on stocks held all quarter
Est. return
+6.5%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$1.16BAdded · 0.0% → 0.1%+11,970,099 shares
- Gilead Sciences Inc~$1.16BAdded · 0.0% → 0.1%+13,498,403 shares
- Ishares Tr~$1.04BAdded · 0.1% → 0.2%+45,559,039 shares
- Netflix~$1.01BAdded · 0.5% → 0.7%+3,440,071 shares
- TSMC~$882.6MAdded · 0.1% → 0.2%+11,848,523 shares
- Boston Scientific Corp~$881.7MAdded · 0.3% → 0.5%+19,055,975 shares
- Meta~$869.1MAdded · 1.6% → 1.5%+7,221,846 shares
- Block~$793.9MAdded · 0.0% → 0.1%+12,634,225 shares
- Intuitive Surgical~$739.2MAdded · 0.1% → 0.2%+2,785,831 shares
- Jpmorgan Chase & Co~$737.0MAdded · 0.4% → 0.6%+5,495,694 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$3.86BCut · 5.1% → 4.1%−29,737,705 shares
- Alphabet~$1.55BCut · 2.4% → 2.0%−17,537,718 shares
- Alphabet~$1.34BCut · 1.4% → 1.1%−15,105,990 shares
- Microsoft~$1.22BCut · 5.0% → 4.7%−5,102,734 shares
- Unitedhealth Group Inc~$1.04BCut · 2.7% → 2.5%−1,965,776 shares
- Vanguard Malvern Fds~$997.0MCut · 0.1% → 0.0%−21,345,416 shares
- Salesforce~$973.3MCut · 0.6% → 0.5%−7,340,497 shares
- Brookfield Asset Mgmt Inc~$891.9MSold out · 0.1% → 0.0%−21,804,432 shares
- Twitter Inc~$806.4MSold out · 0.1% → 0.0%−18,393,704 shares
- Tesla~$781.8MCut · 1.1% → 0.4%−6,346,743 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −2.5% · price +3.0% | 4.7% | $47.72B | +$1.38B | ||||||||
| AppleCOM · shares −8.5% · price −6.0% | 4.1% | $41.73B | −$2.66B | ||||||||
| Unitedhealth Group IncCOM · shares −3.9% · price +5.0% | 2.5% | $25.67B | +$1.22B | ||||||||
| AmazonCOM · shares −1.3% · price −25.7% | 2.5% | $25.04B | −$8.65B | ||||||||
| NvidiaCOM · shares −1.6% · price +20.4% | 2.0% | $20.08B | +$3.40B | ||||||||
| AlphabetCAP STK CL A · shares −7.3% · price −7.8% | 2.0% | $19.65B | −$1.65B | ||||||||
| Exxon Mobil CorpCOM · shares +1.5% · price +26.3% | 1.6% | $15.69B | +$3.22B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.3% · price +15.3% | 1.5% | $14.97B | +$1.98B | ||||||||
| MetaCL A · shares +6.3% · price −11.3% | 1.5% | $14.74B | −$1.77B | ||||||||
| Eli LillyCOM · shares +2.0% · price +13.1% | 1.2% | $12.34B | +$1.40B | ||||||||
| AlphabetCAP STK CL C · shares −11% · price −7.7% | 1.1% | $10.85B | −$907.0M | ||||||||
| Visa Inc.COM CL A · shares +1.1% · price +16.9% | 1.0% | $10.08B | +$1.45B | ||||||||
| MastercardCL A · shares +0.9% · price +22.3% | 0.83% | $8.37B | +$1.51B | ||||||||
| Bank America CorpCOM · shares +5.5% · price +9.7% | 0.80% | $8.08B | +$675.1M | ||||||||
| Regeneron PharmaceuticalsCOM · shares +2.7% · price +4.7% | 0.80% | $8.01B | +$352.6M | ||||||||
| Wells Fargo Co NewCOM · shares +0.3% · price +2.7% | 0.74% | $7.43B | +$191.9M | ||||||||
| NetflixCOM · shares +17% · price +25.2% | 0.69% | $6.92B | +$1.19B | ||||||||
| Danaher CorporationCOM · shares −5.6% · price +2.8% | 0.64% | $6.46B | +$173.6M | ||||||||
| Hess CorpCOM · shares −3.4% · price +30.1% | 0.63% | $6.30B | +$1.46B | ||||||||
| Thermo Fisher Scientific IncCOM · shares +1.7% · price +8.6% | 0.61% | $6.15B | +$477.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares +14% · price +28.3% | 0.60% | $6.01B | +$1.16B | ||||||||
| Lululemon Athletica IncCOM · shares +0.08% · price +14.6% | 0.58% | $5.88B | +$748.9M | ||||||||
| Coca Cola CoCOM · shares −7.1% · price +13.5% | 0.56% | $5.62B | +$671.1M | ||||||||
| Cigna Corp NewCOM · shares +0.5% · price +19.4% | 0.53% | $5.38B | +$871.1M | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +2.9% · price −0.3% | 0.51% | $5.16B | −$13.2M | ||||||||
| Total · 5,337 positions | 100% | $1.01T | +$58.23B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 4,413 stocks held throughout, up $58.23B (+6.5%).
- Nvidia+$3.40B+20%
- Exxon Mobil Corp+$3.22B+26%
- Berkshire Hathaway Inc Del+$1.98B+15%
- Mastercard+$1.51B+22%
- Hess Corp+$1.46B+30%
- Alphabet−$1.65B−8%
- Meta−$1.77B−11%
- Apple−$2.66B−6%
- Tesla−$4.56B−54%
- Amazon−$8.65B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 26 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |